Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-03

Clinical Trial Update: Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Metaderm product for psoriasis, with completed status and results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metaderm product

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2022-10-03